CE & Events
- This event has passed.
VPhA 2022 Virtual Midyear Conference

Join us this February for “2022: The Year of You!” VPhA’s Virtual Midyear Conference!
Midyear has gone Virtual!
VPhA is not excited to move to virtual, but this was the most responsible choice. We know that many of you are busy serving your community and working hard to stay healthy. The last thing VPhA would like to do is be the reason your pharmacy is spread thinner.
VPhA has added on an extra day of programming! Earn up to 13 CE (continuing education) credits, learn timely, state-specific content, and virtually network with your peers.
Registration
Registration IS NOW CLOSED. Check out our Midyear Home Study Series – COMING SOON!
If you registered before January 14, 2022, your registration was transitioned.
Schedule of Events
Friday, February 18, 2022 (4.0 hours of CE)
3:15 PM
VPhA Midyear Meeting Kick-off and Announcements
3:30 PM – 4:30 PM
Medicaid 101: DMAS Pharmacy Program
Janetta Emmelhainz, PharmD; Pharmacy Policy and Data Strategist, Dept of Medical Assistance
UAN #: 0278-0000-22-002-L04-P/T
1.0 Credit Hours; 0.1 CEU
Type: Knowledge
Category: Pharmacy Administration
At the completion of this activity, the participant will be able to:
- Describe the Virginia Medicaid Program Services and Eligibility Groups
- Explain the structure of the Pharmacy Benefit and how the Common Core Formulary relates to covered medications
- Identify and recommend resources available to patients in need of assistance
4:45 PM – 6:15 PM
Racial Trauma: Mending the Body and Heart with Mindfulness
Helen Sairany, BA, MBA, PharmD, RPh, BCACP; SC Pharmacists Association, CEO
UAN #: 0278-0000-22-009-L05-P/T
1.5 Credit Hours; 0.15 CEU
Type: Knowledge
Category: Patient Safety
At the completion of this activity, the participant will be able to:
- Explain trauma and how it is related to mental health.
- Review racial trauma and the impact it has on minority groups.
- Recognize the utility of mindfulness in healing the body and heart from racial trauma.
- Identify effective strategies in incorporating mindfulness into your daily practice
6:30PM – 8:00PM
Substance Use Disorders & Trauma
Paul Brasler, LCSW, CAIP; Dept of Medical Assistance
UAN #: 0278-0000-22-003-L04-P/T
1.5 Credit Hours; 0.15 CEU
Type: Knowledge
Category: Pharmacy Administration
At the completion of this activity, the participant will be able to:
- Understand the different types of trauma
- Recognize the ways individuals respond to trauma
- Explain how trauma is connected with SUD
- Describe how trauma is treated
Saturday, February 19, 2022 (4.5 hours of CE)
7:30 AM
Welcome & Announcements
7:45 AM – 8:45 AM
Rooke Lecture
Five Trends Affecting Your Pharmacy Practice Future
B. Douglas Hoey, RPh, MBA; CEO, National Community Pharmacists Association
UAN #: 0278-0000-22-004-L04-P/T
1.0 Credit Hours; 0.1 CEU
Type: Knowledge
Category: Pharmacy Administration
At the completion of this activity, the participant will be able to:
- Identify at least 3 trends in the pharmacy marketplace that will enhance patient care
- Provide an overview of the evolution of primary care services available to healthcare consumers
- Discuss how changes in the availability, training, and demand for healthcare workers will impact pharmacy practice
9:00 AM – 10:30 AM
SGLT2 Inhibitors in Cardiovascular Disease – Who, What, When, Where, and Why?
Ben Van Tassell, PharmD, BCPS, FCCP, FAHA, ASH-CHC; Professor and Vice-Chair for Research Pharmacotherapy and Outcomes Science, VCU School of Pharmacy
UAN #: 0278-0000-22-005-L01-P/T
1.5 Credit Hours; 0.15 CEU
Type: Knowledge
Category: Disease State Management/Drug Therapy
At the completion of this activity, the participant will be able to:
- Identify patients most likely to benefit from SGLT2 Inhibitors
- Describe the benefits of SGLT2 Inhibitors beyond glucose lowering in patients with diabetes, chronic kidney disease, or heart failure
- Anticipate common risks for a patient taking SGLT2 Inhibitors
- Develop a plan for monitoring outcomes in patients taking SGLT2 Inhibitors
10:45 AM – 11:45 AM
Substance Use Disorders: Stigma, Harm Reduction, and Role of the Pharmacist
Charlie Tarasidis, PharmD; Carilion Clinic
Breanne Forbes Hubbard, MPH; Population Health Manager, Mount Rogers Health District, VDH
Shannon Danny Clawson, MPH; Executive Director, Virginia Harm Reduction Coalition
UAN #: 0278-0000-22-006-L05-P/T
1.0 Credit Hours; 0.1 CEU
Type: Knowledge
Category: Patient Safety
At the completion of this activity, the participant will be able to:
- Review the definition and background of harm reduction in the management of patients with substance use disorders (SUDs)
- Discuss how to reduce societal stigma surrounding treatment and harm reduction associated with SUDs
- Describe case examples of patients who benefit from low threshold or harm reduction care to keep them engaged, and to lower the risks associated with ongoing substance use
- Examine the comprehensive harm reduction and syringe services programs developed by the Virginia Department of Health
- Identify opportunities for integrating harm reduction into your own practice
12:00 PM – 1:00 PM
Introduction to Continuous Glucose Monitoring for Optimal Patient Care
Nicole Slater, PharmD, BCACP; Assoc. Clinical Professor Bernard J. Dunn School of Pharmacy, SU
UAN #: 0278-0000-22-007-L01-P/T
1.0 Credit Hours; 0.1 CEU
Type: Knowledge
Category: Disease State Management/Drug Therapy
At the completion of this activity, the participant will be able to:
- Identify different continuous glucose monitoring systems available to patients
- Compare and Contrast two different continuous glucose monitoring systems
- Describe how to utilize technology for continuous glucose monitoring systems in their practice
- Interpret data from a continuous glucose monitoring system
- Apply findings from continuous glucose monitoring data to a patient case
1:30 PM – 2:30PM
Membership Meeting – Check your email for the Zoom Link on Saturday
(FREE for members, regardless of Midyear registration)
Sunday, February 20, 2022 (4.5 hours of CE)
7:30 AM
Welcome & Announcements
7:45AM – 9:15AM
VDH COVID-19 Updates: Testing, Vaccines, and Therapeutics
Alexis Page, PharmD, BCACP; Healthcare Coordination and Therapeutics Unit Co-Lead, VDH
Chelsea Sprouse, PharmD, BCACP; COVID-19 Vaccine Pharmacy Coordinator, VDH
UAN #: 0278-0000-22-008-L01-P/T
1.5 Credit Hours; 0.15 CEU
Type: Knowledge
Category: Disease State Management/Drug Therapy
At the completion of this activity, the participant will be able to:
- Provide a current overview of COVID-19 in Virginia: Virology, Epidemiology, and Prevention
- Review current pharmacy testing strategies that support COVID-19 public health response
- Identify COVID-19 vaccine candidates and differentiate immunization schedules for individual patients
- Review administration, handling, and storage of current COVID-19 vaccines
- Discuss COVID-19 therapeutics currently available and their role in the pre-exposure, treatment, and post-exposure prophylaxis of COVID-19
9:30 AM – 10:30 AM
Vaccination Update: Get the Facts About the Vax
Riley Fisher, PharmD.; VCU PGY1 Community Pharmacy Resident, Kroger Pharmacy in Roanoke
UAN #: 0278-0000-21-044-L04-P/T
1.0 Credit Hours; 0.1 CEU
Type: Knowledge
Category: Pharmacy Administration
At the completion of this activity, the participant will be able to:
- Identify eligibility criteria and schedules for additional COVID-19 immunization
- Differentiate between each of the pneumococcal vaccinations, and identify proper implementation for their use
- Identify eligibility criteria for any “back-to-school” vaccinations, namely meningococcal and influenza vaccines
10:45 AM – 11:45 AM
Our Opioid Toolbox: Nalox-Dos and Don’ts
Paul McClimon, PharmD; VCU PGY1 Community Pharmacy Resident, Buford Road Pharmacy
UAN #: 0278-0000-21-045-L08-P/T
1.0 Credit Hours; 0.1 CEU
Type: Knowledge
Category: Pain Management
At the completion of this activity, the participant will be able to:
- Discuss the role of a pharmacist as a provider of naloxone and recall the importance of counseling prior to naloxone dispensing
- Summarize the evidence-based rationale for the utilization of naloxone and describe the various formulations for administration
- Identify patients at risk for opioid overdose and determine their eligibility for naloxone dispensing
- Utilize the tools available in the PMP system to aid in identifying patients at risk
12:00 PM – 1:00 PM
The World is Your Oyster, Not Your Ashtray! Initiating Smoking Cessation
Carla Daniel, PharmD; VCU PGY1 Community Pharmacy Resident, Bremo Pharmacy
UAN #: 0278-0000-21-046-L04-P/T
1.0 Credit Hours; 0.1 CEU
Type: Knowledge
Category: Pharmacy Administration
At the completion of this activity, the participant will be able to:
- Differentiate between smoking cessation agents based on mechanism of action, dosing instructions, and side effect profile, and provide pharmacist recommendation for appropriate therapy based on patient presentation
- Implementation of smoking cessation and nicotine replacement therapy in the workflow of the pharmacy
- Recognize and implement the 5 A’s of smoking cessation: Ask, Advise, Assess, Assist, Arrange
40th Annual Rooke Lecture Speaker Bio
CPE Information
Activity Type: Knowledge-based
Target Audience: Pharmacists and pharmacy technicians in all practice settings
All continuing education credits provided by the Virginia Pharmacists Association will be uploaded to the CPE Monitor by Lecture Panda. Lecture Panda is a platform that VPhA utilizes to submit your CE credits. You can access all event materials – PowerPoint slides, assessments, and evaluations on this platform. As soon as you complete your evaluations, they are validated and automatically sent to CPE Monitor for accreditation so there is no wait time to receive credit. After CPE credits are processed by ACPE and NABP, pharmacists and pharmacy technicians are able to log into their NABP e-Profile and view all of their ACPE completed CPE.
The deadline to submit your CE from the VPhA 2022 Virtual Midyear Conference is Monday, March 21, 2022.
The Virginia Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.